NutritionWellnessHerbs & SupplementsLifestyleAbout UsContact Us

Lactobacillus Reuteri Benefits: What the Research Shows

Lactobacillus reuteri (often written as L. reuteri) is one of the more thoroughly studied probiotic bacteria in human gut health research. Unlike many probiotics that simply pass through the digestive tract, L. reuteri is a naturally occurring resident of the human gut microbiome — though not everyone carries it in significant amounts. That distinction matters when looking at what the research shows about its potential benefits.

What Is Lactobacillus Reuteri?

L. reuteri is a gram-positive bacterium found naturally in the digestive tracts of humans and many other mammals. It was first identified in breast milk and the gastrointestinal tracts of healthy individuals, and it has since been isolated from fermented foods, dairy products, and some meat products.

What sets L. reuteri apart from other lactobacillus strains is its ability to produce a natural antimicrobial compound called reuterin (3-hydroxypropionaldehyde), which research suggests may help inhibit the growth of certain harmful bacteria, fungi, and protozoa in the gut without broadly disrupting beneficial microbes. It also produces certain B vitamins, including folate and cobalamin (B12), during fermentation — though the amounts and bioavailability vary considerably.

What Does the Research Generally Show?

🔬 Research into L. reuteri spans several areas, though the evidence varies considerably in strength depending on the specific outcome being studied.

Gut Health and Digestive Function

Several clinical trials have examined L. reuteri in the context of digestive complaints. The evidence is reasonably consistent — though not conclusive — that certain strains may help:

  • Reduce the duration of infectious diarrhea, particularly in infants and young children. Multiple randomized controlled trials (RCTs) support this finding, making it one of the better-established areas of L. reuteri research.
  • Ease symptoms of infant colic. A number of RCTs have found that L. reuteri DSM 17938, a specific strain, was associated with reduced crying time in breastfed infants with colic. Results in formula-fed infants have been more mixed.
  • Support general gut microbiome balance, though the extent to which supplementation durably changes the microbiome varies widely between individuals.

Immune Function

The gut and immune system are closely connected — roughly 70% of immune cells are located in or near the gastrointestinal tract. Some research suggests L. reuteri may interact with gut-associated immune tissue, influencing inflammatory signaling pathways. However, most of this research is preclinical (animal studies or lab-based) or from small human trials. The findings are considered emerging rather than established.

Bone Density

A small but notable clinical trial published in 2018 found that postmenopausal women who took a specific L. reuteri strain showed less bone loss over 12 months compared to a placebo group. This is an intriguing area of ongoing research, but the evidence is early-stage and cannot yet support broad conclusions about bone health.

Metabolic Markers

Some studies have explored connections between L. reuteri supplementation and cholesterol levels, blood glucose regulation, and weight management. Results have been inconsistent across studies. This remains an active area of investigation with limited and mixed evidence to date.

H. pylori Support

Several trials have looked at whether L. reuteri supplementation, alongside standard antibiotic therapy, might improve eradication rates of Helicobacter pylori — a bacterium associated with ulcers and gastric issues. Some evidence suggests it may also help reduce gastrointestinal side effects from antibiotic treatment, though it is not a standalone intervention for H. pylori.

Dietary Sources vs. Supplements

SourceNotes
Fermented dairy (some yogurts, kefir)Strain and live culture content vary by brand and production method
Breast milkNatural source; not a controllable dietary input
Some fermented meatsLess commonly consumed; strain presence is inconsistent
Probiotic supplementsStrain-specific; colony-forming units (CFUs) vary widely

Not all fermented foods contain L. reuteri specifically. Many commercial yogurts use different lactobacillus strains entirely. If L. reuteri is the target, label verification matters — and even then, survivability through the gastrointestinal tract varies by formulation, stomach acid exposure, and individual gut environment.

Factors That Shape Individual Outcomes

Several variables influence how — and whether — L. reuteri has measurable effects in a given person:

  • Strain specificity: Different L. reuteri strains (e.g., DSM 17938, ATCC PTA 6475) have been studied for different outcomes. Benefits observed with one strain don't automatically apply to another.
  • Baseline microbiome composition: People who already have robust L. reuteri populations may respond differently than those who are largely deficient.
  • Age: Research populations have ranged from infants to postmenopausal adults. Age-related shifts in gut microbiota mean results in one group don't reliably translate to another.
  • Diet: High-fiber, plant-rich diets generally support diverse gut bacteria. Diets high in processed foods or low in fermentable fibers may limit probiotic colonization.
  • Antibiotic use: Recent or current antibiotic use significantly disrupts the gut microbiome and can affect how well any probiotic, including L. reuteri, establishes or survives.
  • Dosage and formulation: CFU counts, delivery mechanisms (capsule, liquid, chewable), and whether the product requires refrigeration all affect viability.
  • Underlying health conditions: People with compromised immune systems or serious gastrointestinal conditions may respond very differently than healthy adults.

What This Means for Different People

A healthy adult eating a diverse, fiber-rich diet may see little measurable change from L. reuteri supplementation — their microbiome may already be relatively balanced. An infant with colic, an older adult experiencing age-related microbiome changes, or someone recovering from a course of antibiotics represents a very different biological context, and the research reflects that variability.

The gap between what studies show on average and what any individual experiences is shaped by factors no population-level study can fully account for — your own microbiome composition, diet, health status, and history are the variables that determine where on that spectrum you land.